New results SOMATEX Intra Uterine Shunt

International experts and researchers discussed exciting results and recent developments at the 15th World Congress in Fetal Medicine in Mallorca.

SOMATEX® presented from 26th until June 30th 2016 the new Intra Uterine Shunt (IUS) for treatment of fetuses with obstructive urinary tract disorders and similar antenatal indications. We would like to thank all participants for the great interest in our new products and for fruitful discussions at our booth! We certainly look forward to keeping in touch in the following weeks.

Treatment of lower urinary tract obstruction (LUTO) with the SOMATEX®
Intra Uterine Shunt

Interesting and new results for the SOMATEX® Intra Uterine Shunt have been presented on the world congress by Professor Geipel from the University of Bonn, Germany.

In this study, the authors concluded that vesicoamniotic shunting < 17+0 weeks with the SOMATEX® Intra Uterine Shunt is feasible and associated with a low rate of early dislocation. Vesicoamniotic shunting offers an improved chance of survival, with low pulmonary morbidity. Risk of progression to renal failure pre- or postnatally is still significant. Please do not hesitate to contact us in case you need further information, we will let you know as soon as the published abstract is available.

Our comparison of the new data and complication rates published in the literature for other devices suggests positive results for the SOMATEX® IUS.

 Diagramm-SOMATEX-Shunt_en1

 

 

 

 

 

 

 

 

1: Geipel A et al., Outcomes of fetuses with lower urinary tract obstruction treated with the SOMATEX® vesicoamniotic shunt < 17+0 weeks: A two-center experience, presented during 15th World Congress in Fetal Medicine, Palma de Mallorca
2: Picone O et al., Thoracoamniotic shunting for fetal pleural effusion with hydrops. Am J Ostet Gynecol 2004; 191(6): 2047-2050
3: 30 - 50% rates for shunt displacement, review by: Wilson RD, Johnson MP., Prenatal ultrasound guided percutaneous shunts for obstructive uropathy and thoracic disease. Sem Ped Surg 2003;12(3):182-9

 

Intra Uterine Shunt and Congenital Pulmonary Airway Malformation (CPAM)

Another notable retrospective study on Sonographic Predictors in CPAM was published in March 2016 by Dr. A. Hellmund et al.1. The study investigates the sensitivity of such predictors (e.g. mass-to-thorax-ratio). Please click on the pubmed-link below to see the original article.

Interestingly, shunt related complications were evaluated as well. These complication rates, including shunt migration, are still significant for other products on the market. Therefore, attempting to reduce these device related complications, the hospital is now using the new SOMATEX® Intra Uterine Shunt with self-developing parasols for shunt fixation.

1: Hellmund A et al., Prenatal Diagnosis and Evaluation of Sonographic Predictors for Intervention and Adverse Outcome in Congenital Pulmonary Airway Malformation. PLoS One. 2016 Mar 15;11(3):e0150474.

 

Further information

For more information on the SOMATEX® Intra Uterine Shunt (IUS), please click here.

  • Video of IUS application
  • Product information
  • Further abstracts
  • Detailed instructions for use
  • Additional SOMATEX® products for antenatal diagnostics

If you have any questions concerning our product range in the area of antenatal diagnostics or if you are interested in product presentations, please do not hesitate to get in touch with your SOMATEX® customer representative or our product specialist Mr. Boris Pethe.
 
phone:        + 49 (0)30 319 82 25 – 47
eMail:          b.pethe@somatex.com

 
We are also happy to call you back at a time at your convenience.